loading

Endra Life Sciences Inc Azioni (NDRA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-06-30 2024-03-31 2023-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
11.45%
1.3011
1.4693 2.2309 2.7805 1.4578
Depreciation and Amortization
32.13%
0.00936
0.0138 0.00869 0.0153 0.0219
Operating Income/Loss
11.45%
-1.3011
-1.4693 -2.2309 -2.7805 -1.4578
Income/Loss From Continuing Operations Before Tax
18.29%
-1.2259
-1.0363 -2.2292 -2.7757 -1.4595
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
18.29%
-1.2259
-1.0363 -2.2292 -2.7757 -1.4595
Net Income/Loss
18.29%
-1.2259
-1.0363 -2.2292 2.7757 -1.4595
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - 5.5514 -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research WAT
$306.32
price up icon 2.21%
diagnostics_research DGX
$183.49
price up icon 1.88%
$168.02
price up icon 0.88%
diagnostics_research LH
$278.67
price up icon 1.25%
diagnostics_research MTD
$1,305.71
price up icon 1.39%
diagnostics_research IQV
$187.68
price up icon 1.96%
Capitalizzazione:     |  Volume (24 ore):